Protagenic Therapeutics, Inc.\new (NASDAQ:PTIX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on March 09, 2026.
The Healthcare company reported Q0 revenue of .
Protagenic Therapeutics, Inc.\new's stock currently trades at $0.42 with a market capitalization of $3.0M.
The 10-Q provides Protagenic Therapeutics, Inc.\new's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Protagenic Therapeutics, Inc.\new are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.